who should not take glp-1 receptor agonists and Research to Treat Overeating and Substance Use Disorders Could GLP-1 Receptor Agonists Help
Description
Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M et al (2015) A randomized, controlled trial of 3.0 mg of liraglutide in weight management
The cardiovascular benefits of GLP-1RAs extend beyond their effects on blood glucose levels
Table of Contents: What are GLP-1 medications
The role of GIP in the regulation of GLP-1 satiety and nausea
